Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • DESeq NB test for samples without biological replicates

    Hi guys,

    I hv encountered problems performing negative binomial test for samples without replicates while control group has replicates with DESeq.

    Experimental design:
    conduct the experiment under three conditions with common control: A B C (same samples treated at 3 distinct levels -- 50%, 80%, 95%)
    Condition A has two biological replicates, Condition B and C have no biological replicates, Control group has two biological replicates.
    noted as A_1, A_2, B, C, Ctrl_1, Ctrl_2
    Pipeline of transcriptomic RNA-seq(paired-end):
    map clean reads to ref genome using Tophat -> get the raw counts using SAMtools and HTSeq -> normalized the raw counts matrix using DESeq -> negative binomial test using DESeq

    # Do stats based on a negative binomial distribution from Simon's vignette
    With replicates:
    cds = estimateDispersions(cds)
    results = nbinomTest(cds, "condition", "control")
    Without replicates:
    cds = estimateDispersions(cds, method = "blind")
    results = nbinomTest(cds, "condition", "control")

    So, my confusion goes for a reasonable strategy to conduct NB test without replicates:
    I have two replicates of control group(Ctrl1,Ctrl2) while no replicates for conditon B and conditon C, which way to perform a negative binomial test fits best for this case?
    My current strategy is performing NB test between Ctrl1 and B/C(ignore Ctrl2).

  • #2
    You'll be better off using the control replicates than if you were to use the "blind" method.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      Today, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, 09-06-2024, 08:02 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-03-2024, 08:30 AM
    0 responses
    18 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 08-27-2024, 04:40 AM
    0 responses
    25 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 08-22-2024, 05:00 AM
    0 responses
    387 views
    0 likes
    Last Post seqadmin  
    Working...
    X